Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04866771 · ClinicalTrials.gov registry record · NA
Remotely Supervised tDCS for Slowing ALS Disease Progression
A NA study of Amyotrophic Lateral Sclerosis (ALS), sponsored by University of Illinois at Chicago.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
- 1
- Study location
NCT04866771 is a NA study of Amyotrophic Lateral Sclerosis (ALS) that has completed, run by University of Illinois at Chicago. The registered enrollment target is 14 participants, below the 260-participant average among 17 other Amyotrophic Lateral Sclerosis (ALS) trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04866771, a NA study of Amyotrophic Lateral Sclerosis (ALS), has completed, sponsored by University of Illinois at Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
- 1
- Study location
Study Summary
Most ALS care is centered on patient support and symptom management, making rehabilitation an integral aspect for slowing disease progression, prolonging life span, and increasing quality of life. Brain stimulation has been increasingly explored as a promising neuromodulatory tool to prime motor function in several neurological disorders. We propose a novel mechanism using remotely supervised brain stimulation to preserve motor function in individuals with ALS. This project will also aim to explore the effectiveness of brain stimulation on upper and lower motor neuron mechanisms in individuals with ALS.
Conditions Studied
Interventions
- OTHER Transcranial Direct Current Stimulation (tDCS)
- OTHER Sham tDCS + anodal tDCS
Study Locations (1)
Illinois
- Brain Plasticity Lab - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2021-08-27 |
| Est. Completion | 2025-01-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04866771
The ClinicalTrials.gov registry entry for NCT04866771 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 260-participant average among 17 other Amyotrophic Lateral Sclerosis (ALS) trials with a reported enrollment target (95% lower). The listed sponsor is University of Illinois at Chicago, which has 430 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Amyotrophic Lateral Sclerosis (ALS) appearing as the primary indexed condition, and to 2 interventions - of which Transcranial Direct Current Stimulation (tDCS) is the first listed.
NCT04866771 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.
Frequently Asked Questions
What is clinical trial NCT04866771 about?
NCT04866771 is a clinical study titled "Remotely Supervised tDCS for Slowing ALS Disease Progression". Most ALS care is centered on patient support and symptom management, making rehabilitation an integral aspect for slowing disease progression, prolonging life span, and increasing quality of life. Brain stimulation has been increasingly explored as a promising neuromodulatory tool to prime motor fun...
What is the current status of trial NCT04866771?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2021-08-27. Estimated completion is 2025-01-01.
What conditions does trial NCT04866771 study?
This clinical trial studies the following conditions: Amyotrophic Lateral Sclerosis (ALS).
What interventions are being tested in trial NCT04866771?
The interventions under investigation include: Transcranial Direct Current Stimulation (tDCS) (OTHER), Sham tDCS + anodal tDCS (OTHER).
Who is sponsoring clinical trial NCT04866771?
This trial is sponsored by University of Illinois at Chicago, which has 430 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04866771 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Amyotrophic Lateral Sclerosis (ALS)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neuron Disease.
RECRUITING · NA
-
Examining Interactions Between PALS and Caregivers
RECRUITING · NA
-
Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis
COMPLETED · NA
-
Brain and Nerve Stimulation for Hand Muscles in Spinal Cord Injury and ALS
COMPLETED · NA
-
Healing ALS Registry Observational Study (HAROS)
RECRUITING
-
Mitochondrial Capacity Boost in ALS (MICABO-ALS) Trial
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.